Chronic mild stress-induced alterations of clock gene expression in rat prefrontal cortex: Modulatory effects of prolonged lurasidone treatment

Pharmacological Research

Volumn 104, Issue , 2016, Pages 140-150

  Calabrese, Francesca ^a   Savino, Elisa ^a   Papp, Mariusz ^b   Molteni, Raffaella ^a   Riva, Marco A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME; LURASIDONE; PROTEIN PERS; PROTEIN PPARALPHA; PROTEIN REVERBBETA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CIRCADIAN RHYTHM SIGNALING PROTEIN; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MESSENGER RNA; NEUROLEPTIC AGENT; SEROTONIN 2 ANTAGONIST;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CHRONIC STRESS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LONG TERM EXPOSURE; MAJOR DEPRESSION; MALE; MOLECULAR CLOCK; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; GENETICS; MENTAL STRESS; METABOLISM; WISTAR RAT;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM SIGNALING PEPTIDES AND PROTEINS; DOPAMINE D2 RECEPTOR ANTAGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LURASIDONE HYDROCHLORIDE; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL;

EID: 84953248972     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.12.023     Document Type: Article

References (37)

1. F.W. Turek From circadian rhythms to clock genes in depression Int. Clin. Psychopharmacol. 22 Suppl. 2 2007 S1 S8
2. J. Emens, A. Lewy, J.M. Kinzie, D. Arntz, and J. Rough Circadian misalignment in major depressive disorder Psychiatry Res. 168 3 2009 259 261
3. J. Mendlewicz Disruption of the circadian timing systems molecular mechanisms in mood disorders CNS Drugs 23 2 2009 15 26
4. E.M. Gibson, C. Wang, S. Tjho, N. Khattar, and L.J. Kriegsfeld Experimental 'jet lag' inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters PLoS One 5 12 2010 e15267
5. J.Z. Li, B.G. Bunney, F. Meng, M.H. Hagenauer, D.M. Walsh, M.P. Vawter, S.J. Evans, P.V. Choudary, P. Cartagena, J.D. Barchas, A.F. Schatzberg, E.G. Jones, R.M. Myers, S.J. Watson Jr., H. Akil, and W.E. Bunney Circadian patterns of gene expression in the human brain and disruption in major depressive disorder Proc. Nat. Acad. Sci. U. S. A. 110 24 2013 9950 9955
6. P.L. Lowrey, and J.S. Takahashi Genetics of circadian rhythms in mammalian model organisms Adv. Genet. 74 2011 175 230
7. R.W. Logan, N. Edgar, A.G. Gillman, D. Hoffman, X. Zhu, and C.A. McClung Chronic stress induces brain region-specific alterations of molecular rhythms that correlate with depression-like behavior in mice Biol. Psychiatry 78 4 2015 249 258
8. T. Ishibashi, T. Horisawa, K. Tokuda, T. Ishiyama, M. Ogasa, R. Tagashira, K. Matsumoto, H. Nishikawa, Y. Ueda, S. Toma, H. Oki, N. Tanno, I. Saji, A. Ito, Y. Ohno, and M. Nakamura Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine7(5-HT7) and 5-HT1A receptor activity J. Pharmacol. Exp. Ther. 334 1 2010 171 181
9. L.N. Cates, A.J. Roberts, S. Huitron-Resendiz, and P.B. Hedlund Effects of lurasidone in behavioral models of depression: role of the 5-HT(7) receptor subtype Neuropharmacology 70 2013 211 217
10. T. Horisawa, H. Nishikawa, S. Toma, A. Ikeda, M. Horiguchi, M. Ono, T. Ishiyama, and M. Taiji The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone Behav. Brain Res. 244 2013 66 69
11. F.I. Tarazi, and M.A. Riva The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia Expert Opin. Drug Discov. 8 10 2013 1297 1307
12. A. Luoni, F. Macchi, M. Papp, R. Molteni, and M.A. Riva Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex Int. J. Neuropsychopharmacol. 2014
13. G. Guidotti, F. Calabrese, C. Anacker, G. Racagni, C.M. Pariante, and M.A. Riva Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment Neuropsychopharmacology 38 4 2013 616 627
14. R. Cao, B. Robinson, H. Xu, C. Gkogkas, A. Khoutorsky, T. Alain, A. Yanagiya, T. Nevarko, A.C. Liu, S. Amir, and N. Sonenberg Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling Neuron 79 4 2013 712 724
15. R.M. Buijs, and A. Kalsbeek Hypothalamic integration of central and peripheral clocks Nat. Rev. Neurosci. 2 7 2001 521 526
16. G.H. Son, S. Chung, H.K. Choe, H.D. Kim, S.M. Baik, H. Lee, H.W. Lee, S. Choi, W. Sun, H. Kim, S. Cho, K.H. Lee, and K. Kim Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production Proc. Nat. Acad. Sci. U. S. A. 105 52 2008 20970 20975
17. N. Nader, G.P. Chrousos, and T. Kino Interactions of the circadian CLOCK system and the HPA axis Trends Endocrinol. Metab. 21 5 2010 277 286
18. A.Y. So, T.U. Bernal, M.L. Pillsbury, K.R. Yamamoto, and B.J. Feldman Glucocorticoid regulation of the circadian clock modulates glucose homeostasis Proc. Nat. Acad. Sci. U. S. A. 106 41 2009 17582 17587
19. S. Cheon, N. Park, S. Cho, and K. Kim Glucocorticoid-mediated Period2 induction delays the phase of circadian rhythm Nucleic Acids Res. 41 12 2013 6161 6174
20. K.A. Lamia, S.J. Papp, R.T. Yu, G.D. Barish, N.H. Uhlenhaut, J.W. Jonker, M. Downes, and R.M. Evans Cryptochromes mediate rhythmic repression of the glucocorticoid receptor Nature 480 7378 2011 552 556
21. T. Yamamoto, Y. Nakahata, M. Tanaka, M. Yoshida, H. Soma, K. Shinohara, A. Yasuda, T. Mamine, and T. Takumi Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element J. Biol. Chem. 280 51 2005 42036 42043
22. C. Kinoshita, K. Miyazaki, and N. Ishida Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3beta phosphorylation in the central clock NeuroReport 23 2 2012 98 102
23. W.G. Jiang, S.X. Li, S.J. Zhou, Y. Sun, J. Shi, and L. Lu Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus Brain Res. 1399 2011 25 32
24. W.G. Jiang, S.X. Li, J.F. Liu, Y. Sun, S.J. Zhou, W.L. Zhu, J. Shi, and L. Lu C.L.O.C.K. Hippocampal protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress Psychopharmacology. 227 1 2013 79 92
25. G. Savalli, W. Diao, S. Schulz, K. Todtova, and D.D. Pollak Diurnal oscillation of amygdala clock gene expression and loss of synchrony in a mouse model of depression Int. J. Neuropsychopharmacol. 18 5 2015
26. T. Uz, R. Ahmed, M. Akhisaroglu, M. Kurtuncu, M. Imbesi, A. Dirim Arslan, and H. Manev Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum Neuroscience 134 4 2005 1309 1316
27. F. Calabrese, A. Luoni, G. Guidotti, G. Racagni, F. Fumagalli, and M.A. Riva Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid Psychopharmacology (Berl) 226 1 2013 101 112
28. F. Fumagalli, F. Calabrese, A. Luoni, F. Bolis, G. Racagni, and M.A. Riva Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress Int. J. Neuropsychopharmacol. 15 2 2012 235 246
29. A. Luoni, F.F. Rocha, and M.A. Riva Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 50 2014 94 101
30. T.L. Stan, V.C. Sousa, X. Zhang, M. Ono, and P. Svenningsson Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain Eur. Neuropsychopharmacol. 25 10 2015 1714 1722
31. P.B. Hedlund, S. Huitron-Resendiz, S.J. Henriksen, and J.G. Sutcliffe 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern Biol. Psychiatry 58 10 2005 831 837
32. D.R. Thomas, S. Melotto, M. Massagrande, A.D. Gribble, P. Jeffrey, A.J. Stevens, N.J. Deeks, P.J. Eddershaw, S.H. Fenwick, G. Riley, T. Stean, C.M. Scott, M.J. Hill, D.N. Middlemiss, J.J. Hagan, G.W. Price, and I.T. Forbes SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats Br. J. Pharmacol. 139 4 2003 705 714
33. K. Tokarski, B. Bobula, M. Grzegorzewska-Hiczwa, M. Kusek, and G. Hess Stress- and antidepressant treatment-induced modifications of 5-HT(7) receptor functions in the rat brain Pharmacol. Rep. 64 6 2012 1305 1315
34. M.V. Chakravarthy, Y. Zhu, M. Lopez, L. Yin, D.F. Wozniak, T. Coleman, Z. Hu, M. Wolfgang, A. Vidal-Puig, M.D. Lane, and C.F. Semenkovich Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis J. Clin. Investig. 117 9 2007 2539 2552
35. L.R. Stein, D.F. Wozniak, J.T. Dearborn, S. Kubota, R.S. Apte, Y. Izumi, C.F. Zorumski, and S. Imai Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function J. Neurosci. 34 17 2014 5800 5815
36. A. Luoni, A. Berry, F. Calabrese, S. Capoccia, V. Bellisario, P. Gass, F. Cirulli, and M.A. Riva Delayed BDNF alterations in the prefrontal cortex of rats exposed to prenatal stress preventive effect of lurasidone treatment during adolescence Eur. Neuropsychopharmacol. 24 6 2014 986 995
37. A. Luoni, S. Hulsken, G. Cazzaniga, G. Racagni, J.R. Homberg, and M.A. Riva Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats Int. J. Neuropsychopharmacol. 16 6 2013 1319 1330